Skip to main content

Engineered Biomaterials for Craniofacial Bone Tissue Engineering

No Ratings


2023 AADOCR/CADR Annual Meeting

The 2023 AADOCR/CADR Annual Meeting & Exhibition provided dental, oral, and craniofacial health scientists with the opportunity to present, discuss, and critique their latest and most cutting-edge research at a 100% in-person gathering in Portland, Oregon. The meeting was attended by 2,054 individuals from 39 countries.     

The recordings in this library from the meeting are a selection of the science that was presented at the Annual Meeting. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers and symposia from a collection of scientific groups and networks.

This session can be purchased as part of the full meeting recordings within the product bundles





The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Session Description 
The ultimate goal of bone tissue engineering is the regeneration of a construct that matches the physical and biological properties of the natural bone tissue. Repair and regeneration of craniofacial bone defects have widely been achieved with bone grafting procedures. However, there are several disadvantages associated with this methodology, such as donor site morbidity, hematoma, inflammation, and the high cost of bone harvesting procedures. An advantageous alternative therapeutic option is bone regeneration using mesenchymal stem cells (MSCs). MSCs’ self-renewal and multilineage differentiation capacity provides promising alternative treatment approaches. To guide the differentiation of MSC, it may be necessary and desirable to deliver an appropriate signal that is specific to the desired lineage/phenotype, and hence, exogenous growth factors have been delivered along with stem cells. Furthermore, biomaterials have been utilized to control and manipulate the fate of stem cells leading to high quality tissue regeneration. In this symposia, alternative bone and periodontal tissue regenerative treatment modalities based on concepts of tissue engineering using stem cells and growth factors will be discussed.

Learning Objectives
  • Review the current treatment modality of craniofacial bone tissue regeneration
  • Discuss the potential disadvantages and limitation of bone grafting procedures around dental implants,
  • Introduce and discuss the latest developments in periodontal tissue regeneration and bone tissue engineering, using smart biomaterials and growth factors
Presentation Date
Thursday, March 16, 2023

Presenters
  • David Fraser - Tissue Engineering at Implants and Teeth: Rethinking Classic Concepts for Future Therapies
  • Bo Yu - PGC-1alpha in skeletal aging and craniofacial tissue regeneration
  • Yunsong Liu - The regulation of differentiation of stem cells in bone tissue engineering
Sponsoring Groups/Networks
Implantology Research

CE Credits
1.5 Hours

Financial Interest Disclosure:
NONE

Not eligible for individual purchase must purchase as part of a meeting bundle.